Dogwood Therapeutics Inc. (DWTX)

AI Score

Unlock

5.51

-0.15 (-2.65%)

At close: Apr 25, 2025, 3:59 PM

5.55

0.73%

After-hours: Apr 25, 2025, 05:44 PM EDT

Dogwood Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Net Income	-12.35M	-5.73M	-4.68M	-5.07M	-5.3M	-6.24M	-7.58M	-9.8M	-12.25M	-14.71M	-16.25M	-16.86M	-15.96M	-17.95M	-16.56M	-12.94M	-10.35M	-4.48M	-2.57M	-1.92M	-1.45M	-811.82K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	476.02K	530.52K	584.53K	597.24K	619.97K	621.2K	637.16K	612.45K	582.66K	565.03K	532.67K	429.96K	322.88K	5.62M	7.49M	7.45M	7.43M	2M	n/a	n/a	n/a	n/a
Other Working Capital	-801.16K	816.44K	-17.13K	302.12K	266.81K	-16.16K	-203.4K	-1.12M	-21.92K	12.77K	1.17M	3.49M	-322.2K	-731.84K	-1.67M	-3.7M	-982.4K	266.67K	435.84K	616.85K	512.25K	341.94K
Other Non-Cash Items	3.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-31.31K	-59.78K	-58.2K	-47.48K	-4.03K	36.76K	35.19K	24.46K	12.32K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-581.27K	1.07M	-83.9K	363.79K	-194.45K	-456.53K	-654.63K	-1.32M	197.38K	175.01K	1.58M	3.2M	-52.19K	-436.78K	-1.57M	-3.19M	-930.84K	407.24K	504.42K	623.97K	445.52K	290.79K
Operating Cash Flow	-8.79M	-4.13M	-4.18M	-4.11M	-4.87M	-6.07M	-7.6M	-10.51M	-11.47M	-13.97M	-14.14M	-13.23M	-15.69M	-12.8M	-10.71M	-8.73M	-3.9M	-2.08M	-2.03M	-1.26M	-980.42K	-508.71K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	125K	831.63K	1.99M	2.57M	2.45M	1.74M	580K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	15.32M	n/a	n/a	n/a	n/a	n/a	4.58M	4.58M	4.58M	4.58M	n/a	n/a	-97.6K	31.49M	31.37M	31.29M	31.39M	-201.17K	-96.48K	-16.39K	-16.39K	-10.82K
Financial Cash Flow	15.25M	-70.23K	1.16M	1.16M	1.16M	1.07M	4.49M	4.49M	4.49M	4.58M	n/a	n/a	-97.6K	31.49M	31.49M	32.12M	33.38M	2.37M	2.35M	1.73M	563.61K	-10.82K
Net Cash Flow	11.53M	-2.75M	-1.57M	-2.95M	-3.71M	-5M	-3.1M	-6.02M	-6.98M	-9.4M	-14.14M	-13.23M	-15.79M	18.69M	20.79M	23.39M	29.49M	292.41K	322.29K	468.3K	-416.82K	-519.53K
Free Cash Flow	-8.79M	-4.13M	-4.18M	-4.11M	-4.87M	-6.07M	-7.6M	-10.51M	-11.47M	-13.97M	-14.14M	-13.23M	-15.69M	-12.8M	-10.71M	-8.73M	-3.9M	-2.08M	-2.03M	-1.26M	-980.42K	-508.71K